AEGERA THERAPEUTICS INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6159709 XIAP IRES and uses thereofJul 24, 98Dec 12, 00[A61K, C07H, C12P, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2009/0170,845 USE OF IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE-2-SULFONAMIDE COMPOUNDS TO TREAT NEUROPATHIC PAINAbandonedApr 13, 07Jul 02, 09[A61K]
2009/0142,334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASEAbandonedApr 28, 08Jun 04, 09[A61K, A61P]
2008/0293,653 Method of treating autoimmune diseasesAbandonedOct 12, 05Nov 27, 08[A61K, C12Q, C12N, A61P]
2007/0238,768 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAbandonedMay 07, 07Oct 11, 07[A61K, A61P]
2007/0219,360 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative diseaseAbandonedAug 25, 06Sep 20, 07[C07H]
2007/0202,096 XAF genes and polypeptides: methods and reagents for modulating apoptosisAbandonedAug 04, 06Aug 30, 07[A61K, A01N, C07K]
2007/0203,088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative diseaseAbandonedAug 25, 06Aug 30, 07[C07H]
2007/0142,316 Antisense IAP oligonucleotides and uses thereofAbandonedDec 18, 06Jun 21, 07[A61K, C07H]
2007/0135,371 Antisense IAP nucleobase oligomers and uses thereofAbandonedOct 26, 06Jun 14, 07[A61K, C07H]
2007/0123,481 Antisense IAP oligonucleotides and uses thereofAbandonedJun 30, 06May 31, 07[A61K, C07H]
2007/0112,043 Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereofAbandonedJun 14, 04May 17, 07[A61K, C07D]
2007/0072,217 XAF genes and polypeptides: methods and reagents for modulating apoptosisAbandonedAug 04, 06Mar 29, 07[C07H, C12Q, G01N, C07K]
2007/0032,445 Antisense IAP nucleobase oligomers and uses thereofAbandonedMay 30, 06Feb 08, 07[A61K, C07H, C12N]
2007/0021,416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAbandonedApr 06, 06Jan 25, 07[A61K, C07D]
2007/0009,971 Mammalian IAP gene family, primers, probes, and detection methodsAbandonedDec 22, 05Jan 11, 07[C12N, G01N]
7129250 Neuroprotective and anti-proliferative compoundsExpiredAug 11, 03Oct 31, 06[A61K]
2006/0205,021 Mammalian IAP gene family, primers, probes and detection methodsAbandonedJan 19, 06Sep 14, 06[C12N, G01N, C07K]
2006/0199,835 Neuroprotective and anti-proliferative compoundsAbandonedAug 11, 04Sep 07, 06[A61K, C07D]
2006/0189,563 Detection and modulation of IAPS and NAIP for the diagnosis and treatment of proliferative diseaseAbandonedMar 20, 06Aug 24, 06[A61K]
7067281 Mammalian IAP gene family, primers, probes and detection methodsExpiredJun 20, 03Jun 27, 06[C12P]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.